OS Therapies OSTX Q4 2025 Earnings WiderThanExpected Loss Weighs on Shares Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses MAN Q1 2026 Earnings Earnings Beat Expectations Amid Difficult Staffing Environment PSA Q1 2026 Earnings EPS Surpasses Estimates by 124 as Occupancy and Expense Control Drive Results FRPH Q4 2024 Earnings Modest Earnings Amid Stock Decline American Realty Investors Inc Q3 2024 Earnings Negative EPS of 108 as Losses Persist Stock Declines